Gadolinium (Gd) contrast agents have been used instead of iodinated contrast agents in patients in whom iodine is contraindicated, but cerebral angiography of a dural arteriovenous fistula (dAVF) using a Gd contrast agent has not previously been reported. We recently performed cerebral angiography using a Gd contrast agent in a patient with an anterior condylar confluence dAVF who was allergic to iodine. To our surprise, there was spontaneous closure of the dAVF immediately after angiography. We now report what we believe is the first such case report.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2014.06.019 | DOI Listing |
BMC Neurol
January 2025
Department of Neurosurgery, Gifu University Graduate School of Medicine, 1-1, Yanagido, Gifu, 501-1194, Japan.
Background: Tyrosine kinase inhibitors (TKIs) improve prognosis in chronic myeloid leukemia (CML). Nilotinib and ponatinib, second- and third-generation TKIs, respectively, have been reported to cause adverse vascular occlusive events such as myocardial infarction and peripheral arterial disease. However, little is known about the risk of cerebral infarction associated with severe cerebrovascular stenosis, which is a late complication of TKIs.
View Article and Find Full Text PDFJ Neurointerv Surg
January 2025
Interventional Neuroradiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Intrasaccular flow disruption has become established for the treatment of wide necked and bifurcation aneurysms. The most successful current devices are the WEB (Microvention) and Contour (Stryker). The Artisse (Medtronic) is a novel intrasaccular device designed to treat a variety of aneurysm morphologies.
View Article and Find Full Text PDFJ Neurointerv Surg
January 2025
Department of Neurosurgery, Geisinger Medical Center, Danville, Pennsylvania, USA.
J Neurointerv Surg
January 2025
Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria.
Background And Purpose: This study evaluates the early clinical performance of the new Artisse Intrasaccular Device (Artisse ISD), a self-expandable intrasaccular flow diverter, for treating wide-necked aneurysms (WNAs). We report initial safety and efficacy outcomes in the first cohort of patients treated with this novel device.
Methods: Prospective clinical and radiological data were collected for all patients treated with the Artisse ISD at three Austrian neurovascular centers from July 2023 to August 2024.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!